Noida, India · Mississauga, Canada

Email us
Injections Supportive care

Fosa TECH

Fosaprepitant Dimeglumine Injection

Fosa TECH - Fosaprepitant Dimeglumine Injection

Product pack shot.

A single-dose NK1 receptor antagonist given before chemotherapy to prevent the nausea and vomiting that make patients dread their next cycle.

150 mg
Product specification
BrandFosa TECH
CompositionFosaprepitant Dimeglumine Injection
Dosage formLyophilised powder for solution for infusion
Strengths150 mg
PresentationSingle-dose vial
Therapeutic areaSupportive care
CategoryPrescription only (Rx)

Product information

About Fosaprepitant Dimeglumine

  • Prodrug of aprepitant; substance P / NK1 receptor antagonist.
  • Prevention of acute and delayed chemotherapy-induced nausea and vomiting with highly and moderately emetogenic regimens.
  • One 150 mg intravenous infusion on day 1, given with a 5-HT3 antagonist and dexamethasone.
  • Store vials at 2–8 °C.

Hospitals · Distributors · Oncology centres

Talk to us about supply, pricing or partnership.

Share the molecule, strength and approximate monthly requirement. We reply to every genuine enquiry within two working days.